A proof-of-concept for future precision was recently demonstrated in some studies, where the teams used a Transient Receptor Potential Melastatin 8 channel (TRPM8) agonist, an ion channel in the plasma membrane, encapsulated into a Lipid NanoCapsule in order to inhibit PCa cell migration. The gene discussed is TRPM8; the disease is posterior cortical atrophy.